Home / Wiki / G / Genomics

Genomics

Investment and Capital MarketsUpdated 16 Nov 2026

Genomics is the study of the genome, the complete set of DNA that carries the instructions for building and running an organism. Its basic tool is sequencing, the reading of the order of the chemical letters in DNA. The first full human sequence was completed in 2003 after more than a decade of work. The cost of sequencing a genome has since fallen by several orders of magnitude, which has moved the technique from research into routine medicine.

Applications include tests for inherited disease, the matching of cancer drugs to the mutations in a tumour, the discovery of new medicines and crop breeding. Investors treat genomics as a theme within thematic investing, covering makers of sequencing equipment, testing companies and developers of gene editing and related treatments. It connects with epigenomics and with AI-developed drugs. Returns have been uneven.

Last updated 16 Nov 2026